TransCode Therapeutics, Inc. , a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease.
Transcode Therapeutics stock last closed at $11.20, up 2.28% from the previous day, and has decreased 97.39% in one year. It has underperformed other stocks in the Biotechnology industry by 0.77 percentage points. Transcode Therapeutics stock is currently +82.17% from its 52-week low of $6.15, and -97.78% from its 52-week high of $504.97.
There are currently 833,683 shares of RNAZ outstanding. The market cap of RNAZ is $9.34M. In the last 24 hours, 15,500 RNAZ shares were traded.
You need an online brokerage account to access the NASDAQ market and buy RNAZ shares.
Based on our analysis, eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, it's time to fill out some personal info so you can buy RNAZ stock today.
Now that you've opened your account on one of the most highly reviewed stock market apps, you can securely and quickly fund your account:
Watch this video walkthrough if you need help transferring funds into your investment account.
After you have decided on the best place to buy Transcode Therapeutics stock, it's absolutely critical to evaluate their stock before you invest, so you can understand the risk and upside.
WallStreetZen was created to help part-time investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on RNAZ's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge RNAZ's true value.
Using relative valuations measures:
You can do additional valuation analysis on RNAZ's stock here.
You can dig deeper into what analysts are projecting on the Transcode Therapeutics stock forecast page.
Over the last 12 months, executives and large shareholders at RNAZ have not bought or sold any shares.
Dig into more about who owns RNAZ stock here.
No, Transcode Therapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two primary options:
Click the Open button and your broker will place your order.
If you require more assistance buying stocks on eToro, click the helpful video below:
Now that you own some RNAZ stock, you'll want to keep up with your company.
Make a watchlist to track the most important metrics related to your RNAZ stock.
To reiterate, here are the 6 steps you need to take to buy Transcode Therapeutics stock right now:
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your new investment in Transcode Therapeutics, create your watchlist below.